CDB20:0002845 NCR3LG1 — NCR3

Experimentally validated in Human; Orthology-inferred in Rat, Frog, Zebrafish, Macaque, Dog, Cow, Chimp, Horse, Sheep

Title

Journal:; Year Published:

Abstract

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

The Journal of experimental medicine, 2009; PubMed, Homo sapiens NCR3LG1 — Homo sapiens NCR3
ABSTRACT: Cancer development is often associated with the lack of specific and efficient recognition of tumor cells by the immune system. Natural killer (NK) cells are lymphocytes of the innate immune system that participate in the elimination of tumors. We report the identification of a tumor cell surface molecule that binds NKp30, a human receptor which triggers antitumor NK cell cytotoxicity and cytokine secretion. This previously unannotated gene belongs to the B7 family and, hence, was designated B7-H6. B7-H6 triggers NKp30-mediated activation of human NK cells. B7-H6 was not detected in normal human tissues but was expressed on human tumor cells, emphasizing that the expression of stress-induced self-molecules associated with cell transformation serves as a mode of cell recognition in innate immunity.
Basic Information on NCR3LG1
Ligand Name: natural killer cell cytotoxicity receptor 3 ligand 1
Other Symbols: DKFZp686O24166, B7-H6
Ligand Location: secreted based on perplexity, cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: NCR3LG1
GeneCards: NCR3LG1
Interactions with other Receptors for NCR3LG1
Basic Information on NCR3
Receptor Name: natural cytotoxicity triggering receptor 3
Other Symbols: LY117, 1C7, NKp30, CD337
Receptor Location: cell membrane based on perplexity, uniprot
HGNC Gene Symbol Report: NCR3
GeneCards: NCR3
Interactions with other Ligands for NCR3